Luyan PharmaLtd Beheer

Beheer criteriumcontroles 3/4

De CEO Luyan PharmaLtd is Jinxiang Wu, benoemd in Sep2008, heeft een ambtstermijn van 16.17 jaar. bezit rechtstreeks 1.24% van de aandelen van het bedrijf, ter waarde CN¥ 41.19M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 5.6 jaar en 7.1 jaar.

Belangrijke informatie

Jinxiang Wu

Algemeen directeur

CN¥2.1m

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	16.2yrs
Eigendom CEO	1.2%
Management gemiddelde ambtstermijn	5.6yrs
Gemiddelde ambtstermijn bestuur	7.1yrs

Recente managementupdates

Recent updates

The Returns On Capital At Luyan PharmaLtd (SZSE:002788) Don't Inspire Confidence

Sep 30

CEO

Jinxiang Wu (62 yo)

16.2yrs

Tenure

CN¥2,146,400

Compensatie

Mr. Jinxiang Wu serves as the Chairman of the Board of Directors and General Manager at Luyan Pharma Co.,Ltd. (formerly known as Luyan (Fujian) Pharma Co. Ltd.) Mr. Wu serves as Executive Director of Xiame...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Jinxiang Wu	Chairman & GM	16.2yrs	CN¥2.15m	1.24% CN¥ 41.2m
Di Wu	Deputy GM & Vice Chairman	7.1yrs	CN¥1.54m	geen gegevens
Zheng Zeng	Financial Director & Accounting Supervisor	1.1yrs	CN¥58.10k	geen gegevens
Lei Ming	Deputy GM	no data	CN¥1.97m	0.12% CN¥ 4.1m
Qizhuan Xu	Assistant to Chairman & Director	1.8yrs	CN¥110.00k	geen gegevens
Quanqing Ye	Secretary	5.2yrs	CN¥961.30k	geen gegevens
Ming Guo Zhu	Deputy General Manager	15.8yrs	CN¥1.95m	0.26% CN¥ 8.5m
Wei Yang Li	Deputy General Manager	15.8yrs	CN¥2.08m	1.04% CN¥ 34.5m
Jun Ying Zhang	Deputy General Manager	15.8yrs	CN¥1.38m	0.92% CN¥ 30.7m
Jin Liu	Deputy General Manager	5.6yrs	CN¥1.67m	geen gegevens
Cuiping Li	Internal Audit Director & Supervisor	no data	geen gegevens	0.00031% CN¥ 10.3k

5.6yrs

Gemiddelde duur

49yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 002788 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 5.6 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Jinxiang Wu	Chairman & GM	16.2yrs	CN¥2.15m	1.24% CN¥ 41.2m
Di Wu	Deputy GM & Vice Chairman	7.1yrs	CN¥1.54m	geen gegevens
Lei Ming	Deputy GM	16.2yrs	CN¥1.97m	0.12% CN¥ 4.1m
Qizhuan Xu	Assistant to Chairman & Director	1.1yrs	CN¥110.00k	geen gegevens
Cuiping Li	Internal Audit Director & Supervisor	12.5yrs	geen gegevens	0.00031% CN¥ 10.3k
Mei Zhen Cai	Chairman of Supervisory Board	13.1yrs	geen gegevens	0.033% CN¥ 1.1m
Jun Long Wu	Independent Director	1.1yrs	CN¥10.00k	geen gegevens
Biyun Lin	Supervisor	7.1yrs	geen gegevens	0.00071% CN¥ 23.6k
Shaoqin Ye	Independent Director	3.5yrs	CN¥98.00k	geen gegevens
Peilin Song	Independent Director	1.1yrs	CN¥10.00k	geen gegevens

7.1yrs

Gemiddelde duur

56.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 002788 wordt beschouwd als ervaren (gemiddelde ambtstermijn 7.1 jaar).

Luyan PharmaLtd Beheer

Beheer criteriumcontroles 3/4

Belangrijke informatie

Recente managementupdates

Luyan Pharma Co.,Ltd., Annual General Meeting, May 07, 2024

Less than half of directors are independent

Less than half of directors are independent

Luyan Pharma Co.,Ltd. Announces Board Appointments

Insufficient new directors

Recent updates

Third quarter 2024 earnings released: EPS: CN¥0.17 (vs CN¥0.18 in 3Q 2023)

Luyan Pharma Co.,Ltd. to Report Q3, 2024 Results on Oct 22, 2024

Investor sentiment improves as stock rises 22%

The Returns On Capital At Luyan PharmaLtd (SZSE:002788) Don't Inspire Confidence

Second quarter 2024 earnings released: EPS: CN¥0.27 (vs CN¥0.28 in 2Q 2023)

Luyan Pharma Co.,Ltd. to Report First Half, 2024 Results on Aug 22, 2024

Luyan Pharma Co.,Ltd. Announces Final Cash Dividend (A Shares) for the Year 2023, Payable on July 4, 2024

Full year 2023 earnings released: EPS: CN¥0.94 (vs CN¥0.89 in FY 2022)

Luyan Pharma Co.,Ltd., Annual General Meeting, May 07, 2024

Luyan Pharma Co.,Ltd. to Report Q1, 2024 Results on Apr 16, 2024

Investor sentiment deteriorates as stock falls 16%

Luyan Pharma Co.,Ltd. to Report Fiscal Year 2023 Results on Apr 16, 2024

Less than half of directors are independent

Less than half of directors are independent

Luyan Pharma Co.,Ltd. Announces Board Appointments

Third quarter 2023 earnings released: EPS: CN¥0.18 (vs CN¥0.22 in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.28 (vs CN¥0.25 in 2Q 2022)

Luyan Pharma Co.,Ltd. to Report First Half, 2023 Results on Aug 08, 2023

Luyan Pharma Co.,Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on June 14, 2023

First quarter 2023 earnings released: EPS: CN¥0.21 (vs CN¥0.18 in 1Q 2022)

Insufficient new directors

Third quarter 2022 earnings released: EPS: CN¥0.22 (vs CN¥0.20 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.25 (vs CN¥0.22 in 2Q 2021)

Luyan Pharma Co.,Ltd. Announces Cash Dividend for A Shares for the Year 2021, Payable on 06 July 2022

Luyan Pharma Co.,Ltd. Announces Cash Dividend for the Year 2021

Luyan Pharma Co.,Ltd. Proposes Final Cash Dividend for the Year 2021

First quarter 2022 earnings released: EPS: CN¥0.18 (vs CN¥0.17 in 1Q 2021)

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.20 (vs CN¥0.25 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.22 (vs CN¥0.24 in 2Q 2020)

Luyan Pharma Co.,Ltd. Approves Cash Dividend for the Year 2020

Luyan Pharma Co.,Ltd. Announces Profit Distribution Proposal for 2020

First quarter 2021 earnings released: EPS CN¥0.17 (vs CN¥0.16 in 1Q 2020)

New 90-day low: CN¥7.18

New 90-day low: CN¥7.81

New 90-day low: CN¥8.41

Third quarter earnings released

Luyan Pharma Co.,Ltd. to Report Q3, 2020 Results on Oct 27, 2020

Luyan Pharma Co.,Ltd. has completed a Follow-on Equity Offering in the amount of CNY 338.657765 million.

New 90-day low: CN¥8.54

Earnings released

Luyan Pharma Co.,Ltd. to Report First Half, 2020 Results on Aug 25, 2020

New 90-day high - CN¥10.93

Luyan Pharma Co.,Ltd. announced a financing transaction

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd